Andrographis is a plant that is native to South Asian countries such as India and Sri Lanka. The leaf and underground stem are used to make medicine.
Andrographis is used for the common cold, osteoarthritis, infection of the throat and tonsils (tonsillopharyngitis), a type of inflammatory bowel disease (ulcerative colitis), and many other conditions, but there is no good scientific evidence to support these uses.
Is a Form of:
Common cold, osteoarthritis
Also Known As:
Andrographis paniculata, Andrographolide, Bhunimba
How Does It Work?
Andrographis might work by stimulating the immune system. It might also prevent influenza viruses from binding to cells in the body.
- Common cold. Taking andrographis alone or as part of an herbal combination product seems to improve cough and sore throat in some people with the common cold. Some research also shows that taking a combination product (Kan Jang, Swedish Herbal Institute) containing andrographis and eleuthero improves symptoms of the common cold when started within 72 hours of feeling sick. Some symptoms can improve after 2 days of treatment, but it usually takes 4-5 days of treatment before most symptoms go away. Some research shows that this combination product relieves cold symptoms in children better than echinacea. Also, early research shows that taking an andrographis extract (KalmCold) alone might help treat colds. Other research shows that taking andrographis alone for 2 months might help prevent colds.
- Osteoarthritis. Some research shows that taking andrographis extract daily seems to reduce pain and stiffness in people with mild or moderate osteoarthritis of the knee.
- Infection of the throat and tonsils (tonsillopharyngitis). Some research shows that andrographis 6 grams daily works about as well as acetaminophen (Tylenol) to reduce fever and pain from tonsillitis.
- A type of inflammatory bowel disease (ulcerative colitis). Early research shows that taking andrographis extract daily for 8 weeks reduces symptoms of inflammatory bowel disease about as well as the drug mesalamine.
The following doses have been studied in scientific research:
- For common cold: A specific combination product (Kan Jang, Swedish Herbal Institute) containing andrographis extract, standardized to contain 4-5.6 mg andrographolide, and 400 mg eleuthero has been taken three times daily. A specific andrographis extract (KalmCold) 200 mg daily has been used for 5 days.
- For osteoarthritis: Andrographis extract 300 or 600 mg daily for 12 weeks.
- For infection of the throat and tonsils (tonsillopharyngitis): Andrographis 3-6 grams daily.
- For a type of inflammatory bowel disease (ulcerative colitis): Andrographis extract 1200-1800 mg daily for 8 weeks.
Andrographis Supplements Frequently Asked Questions
What is Andrographis used for?
Andrographis paniculata Wall (family Acanthaceae) is one of the most popular medicinal plants used traditionally for the treatment of array of diseases such as cancer, diabetes, high blood pressure, ulcer, leprosy, bronchitis, skin diseases, flatulence, colic, influenza, dysentery, dyspepsia and malaria for centuries .
Does Andrographis really work?
Some research shows that this combination product relieves cold symptoms in children better than echinacea. Also, early research shows that taking an andrographis extract (KalmCold) alone might help treat colds. Other research shows that taking andrographis alone for 2 months might help prevent colds.
How do you take Andrographis?
For treating the common cold: a combination of a specific andrographis extract, standardized to contain 4-5.6 mg andrographolide, plus 400 mg Siberian ginseng (Kan Jang, Swedish Herbal Institute) three times daily. For relieving fever and sore throat in tonsillitis: 3-6 grams daily.
Can you take Andrographis daily?
Dosage and Preparation
There is no single recommended dose of Andrographis. Various doses have been studied in research. ... For the relief of sore throat, a dose of 3-6 grams Andrographis was used daily. And for ulcerative colitis Andrographis extract, 1200-1800 mg was used daily for eight weeks.
Is Andrographis a blood thinner?
Andrographis has been used in combination with other herbs for up to one month. ... Bleeding conditions: Andrographis might slow blood clotting. This might increase the risk of bleeding or bruising in people with bleeding disorders. Low blood pressure: Research suggests that andrographis might lower blood pressure.
Is Andrographis antiviral?
Also known as "Indian echinacea," andrographis is a bitter-tasting herb rich in compounds known as andrographolides. These compounds are thought to have anti-inflammatory, antiviral, and antioxidant properties.
How long can I take Andrographis?
Andrographis is LIKELY SAFE when taken by mouth appropriately, short-term. It also appears to be safe when taken as a specific combination product containing andrographis extract and Siberian ginseng (Kan Jang, Swedish Herbal Institute) for up to 3 months
What are the side effects of Andrographis?
Andrographis can cause side effects such as loss of appetite, diarrhea, vomiting, rash, headache, runny nose, and fatigue. When used in high doses, andrographis might cause swollen lymph glands, serious allergic reactions, elevations of liver enzymes, and other side effects.
How much Andrographis should I take?
There is no single recommended dose of Andrographis. Various doses have been studied in research. For example, in studies examining the effect of the herb on the common cold, a combination product (4-5.6 mg andrographolide, and 400 mg Siberian ginseng) was taken three times daily.
Does Andrographis kill Candida?
Andrographis: “The King of Bitters” is a perfect herb for Candida as it has strong antifungal properties, protects the liver, while also being great for boosting the immune system. This herb is used in the Sanctuary Candida and Parasite Detox designed by me, or is also available online here.
Does Andrographis lower blood pressure?
Low blood pressure: Research suggests that andrographis might lower blood pressure. This has not been seen in humans. In theory, however, andrographis might lower pressure too much if taken by people who already have low blood pressure.
What are the health benefits of Andrographis?
Andrographis is most widely used to treat cold and flu symptoms. Andrographis is also said to act as a natural immune-booster. The herb is also used to treat certain other conditions.
- Rheumatoid Arthritis2
- Heart disease.
- Liver problems.
Is Andrographis an adaptogen?
Critical analysis of available preclinical and clinical information on Andrographis paniculata extracts and pure andrographolide strongly suggest that they are pharmacologically polyvalent and that they possess adaptogenic properties.
What is the common name of Andrographis paniculata?
Andrographis paniculata, commonly known as creat or green chireta, is an annual herbaceous plant in the family Acanthaceae, native to India and Sri Lanka.
What is the herb Andrographis?
Andrographis (Andrographis paniculata) is an herb long used in traditional Chinese medicine and ayurveda. Also known as "Indian echinacea," andrographis is a bitter-tasting herb rich in compounds known as andrographolides. These compounds are thought to have anti-inflammatory, antiviral, and antioxidant properties.
Is Andrographis good for cold and flu?
Take andrographis at the first sign of a cold or flu to help fight symptoms including runny nose, coughs, sore throat, headache, earache, fever & fatigue. For immune support, andrographis can be taken at a lower dose before any signs of cold or flu symptoms.
Does Andrographis kill parasites?
In addition to being an anti-spirochetal herb, andrographis also has anti-parasitic properties, enhances immune function, protects the heart, is anti-inflammatory and crosses the blood brain barrier, which enables it to access pathogens in the brain.
- ^ ab c d e f Melchior J, et al. Double-blind, placebo-controlled pilot and phase III study of activity of standardized Andrographis paniculata Herba Nees extract fixed combination (Kan jang) in the treatment of uncomplicated upper-respiratory tract infection. Phytomedicine. (2000)
- ^ ab c Gabrielian ES, et al. A double blind, placebo-controlled study of Andrographis paniculata fixed combination Kan Jang in the treatment of acute upper respiratory tract infections including sinusitis. Phytomedicine. (2002)
- ^ ab Mkrtchyan A, et al. A phase I clinical study of Andrographis paniculata fixed combination Kan Jang versus ginseng and valerian on the semen quality of healthy male subjects. Phytomedicine. (2005)
- ^ ab Spasov AA, et al. Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children. Phytother Res. (2004)
- ^ ab Amaryan G, et al. Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard--a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever. Phytomedicine. (2003)
- ^ ab c d e Varma A, Padh H, Shrivastava N. Andrographolide: a new plant-derived antineoplastic entity on horizon. Evid Based Complement Alternat Med. (2011)
- ^ ab c Coon JT, Ernst E. Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Med. (2004)
- ^ ab c d e f Saxena RC, et al. A randomized double blind placebo controlled clinical evaluation of extract of Andrographis paniculata (KalmCold) in patients with uncomplicated upper respiratory tract infection. Phytomedicine. (2010)
- ^ ab c d e Akbar S. Andrographis paniculata: a review of pharmacological activities and clinical effects. Altern Med Rev. (2011)
- ^Balachandran P, Govindarajan R. Cancer--an ayurvedic perspective. Pharmacol Res. (2005)
- ^He CL, et al. Xiang-Qi-Tang and its active components exhibit anti-inflammatory and anticoagulant properties by inhibiting MAPK and NF-κB signaling pathways in LPS-treated rat cardiac microvascular endothelial cells. Immunopharmacol Immunotoxicol. (2012)
- ^ ab c d e f g Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian).
- ^ ab c d Pholphana N, et al. Changes in the contents of four active diterpenoids at different growth stages in Andrographis paniculata (Burm.f.) Nees (Chuanxinlian). Chin Med. (2013)
- ^QUANTITATIVE HPLC ANALYSIS OF ANDROGRAPHOLIDE IN ANDROGRAPHIS PANICULATA AT TWO DIFFERENT STAGES OF LIFE CYCLE OF PLANT.
- ^ ab Smith PL, et al. Bisandrographolide from Andrographis paniculata activates TRPV4 channels. J Biol Chem. (2006)
- ^Bhaskar Reddy MV, et al. New 2'-oxygenated flavonoids from Andrographis affinis. J Nat Prod. (2003)
- ^Radhika P, Prasad YR, Lakshmi KR. Flavones from the stem of Andrographis paniculata Nees. Nat Prod Commun. (2010)
- ^ ab c Anti-inflammatory Activity of New Compounds from Andrographis paniculata by NF-κB Transactivation Inhibition.
- ^Flavonoids of andrographis paniculata.
- ^ ab Pholphana N, et al. Determination and variation of three active diterpenoids in Andrographis paniculata (Burm.f.) Nees. Phytochem Anal. (2004)
- ^Cheung HY, Cheung CS, Kong CK. Determination of bioactive diterpenoids from Andrographis paniculata by micellar electrokinetic chromatography. J Chromatogr A. (2001)
- ^ ab Burgos RA, et al. Testicular toxicity assessment of Andrographis paniculata dried extract in rats. J Ethnopharmacol. (1997)
- ^ ab Vincent F, Duncton MA. TRPV4 agonists and antagonists. Curr Top Med Chem. (2011)
- ^Ye L, et al. TRPV4 is a regulator of adipose oxidative metabolism, inflammation, and energy homeostasis. Cell. (2012)
- ^ ab c d e f g h i j k Panossian A, et al. Pharmacokinetic and oral bioavailability of andrographolide from Andrographis paniculata fixed combination Kan Jang in rats and human. Phytomedicine. (2000)
- ^ ab c Ye L, et al. Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoprotein. J Pharm Sci. (2011)
- ^Xu L, et al. A simple and sensitive HPLC-ESI-MS/MS method for the determination of andrographolide in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. (2009)
- ^Cui L, et al. Four new andrographolide metabolites in human urine. Chem Pharm Bull (Tokyo). (2004)
- ^He X, et al. Identification of a rare sulfonic acid metabolite of andrographolide in rats. Drug Metab Dispos. (2003)
- ^[Studies on the structure of the adduct of andrographolide with sodium hydrogen sulfite (author's transl).
- ^ ab Pan Y, et al. In vitro modulatory effects of Andrographis paniculata, Centella asiatica and Orthosiphon stamineus on cytochrome P450 2C19 (CYP2C19). J Ethnopharmacol. (2011)
- ^Ismail S, et al. Effects of Andrographis paniculata and Orthosiphon stamineus extracts on the glucuronidation of 4-methylumbelliferone in human UGT isoforms. Molecules. (2010)
- ^ ab c d e Chao WW, et al. Inhibitory Effects of Ethyl Acetate Extract of Andrographis paniculata on NF-κB Trans-Activation Activity and LPS-Induced Acute Inflammation in Mice. Evid Based Complement Alternat Med. (2011)
- ^Taub DD. Chemokine-leukocyte interactions. The voodoo that they do so well. Cytokine Growth Factor Rev. (1996)
- ^Zwijnenburg PJ, et al. CXC-chemokines KC and macrophage inflammatory protein-2 (MIP-2) synergistically induce leukocyte recruitment to the central nervous system in rats. Immunol Lett. (2003)
- ^ ab c d Zhang C, Kuroyangi M, Tan BK. Cardiovascular activity of 14-deoxy-11,12-didehydroandrographolide in the anaesthetised rat and isolated right atria. Pharmacol Res. (1998)
- ^ ab Yoopan N, et al. Cardiovascular effects of 14-deoxy-11,12-didehydroandrographolide and Andrographis paniculata extracts. Planta Med. (2007)
- ^Lien LM, et al. Mechanisms of Andrographolide-Induced Platelet Apoptosis in Human Platelets: Regulatory Roles of the Extrinsic Apoptotic Pathway. Phytother Res. (2013)
- ^ ab c d e f g h i Kumar RA, et al. Anticancer and immunostimulatory compounds from Andrographis paniculata. J Ethnopharmacol. (2004)
- ^ ab c d e Calabrese C, et al. A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res. (2000)
- ^Leelarasamee A, Trakulsomboon S, Sittisomwong N. Undetectable anti-bacterial activity of Andrographis paniculata (Burma) wall. ex ness. J Med Assoc Thai. (1990)
- ^ ab c Thamlikitkul V, et al. Efficacy of Andrographis paniculata, Nees for pharyngotonsillitis in adults. J Med Assoc Thai. (1991)
- ^Cáceres DD, et al. Use of visual analogue scale measurements (VAS) to asses the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized double blind-placebo study. Phytomedicine. (1999)
- ^ ab Burgos RA, et al. Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial. Clin Rheumatol. (2009)
- ^ ab c Allan JJ, et al. Reproductive and fertility effects of an extract of Andrographis paniculata in male Wistar rats. Int J Toxicol. (2009)
- ^ ab Krithika R, Verma R, Shrivastav P. Antioxidative and cytoprotective effects of andrographolide against CCl4-induced hepatotoxicity in HepG2 cells. Hum Exp Toxicol. (2012)
- ^Ye JF, et al. Protective mechanism of andrographolide against carbon tetrachloride-induced acute liver injury in mice. Biol Pharm Bull. (2011)
- ^Singh J, Reen RK. In vitro assessment of paracetamol-induced toxicity in the rat Reuber hepatoma H4IIEC3/G(-) cell line competent of xenobiotics metabolism. Toxicol In Vitro. (1999)
- ^Guan S, et al. Andrographolide protects against cigarette smoke-induced oxidative lung injury via augmentation of Nrf2 activity. Br J Pharmacol. (2012)
- ^Aboumarzouk OM, et al. Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev. (2012)
- ^Muangman V, et al. The usage of Andrographis paniculata following Extracorporeal Shock Wave Lithotripsy (ESWL). J Med Assoc Thai. (1995)
- ^Michelsen KS, et al. HMPL-004 (Andrographis paniculata extract) Prevents Development of Murine Colitis by Inhibiting T-cell Proliferation and TH1/TH17 Responses. Inflamm Bowel Dis. (2012)
- ^Michelsen KS, et al. HMPL-004 (Andrographis paniculata extract) Prevents Development of Murine Colitis by Inhibiting T-cell Proliferation and TH1/TH17 Responses. Inflamm Bowel Dis. (2013)
- ^Tang T, et al. Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther. (2011)
- ^Sandborn WJ, et al. Andrographis paniculata Extract (HMPL-004) for Active Ulcerative Colitis. Am J Gastroenterol. (2013)
- ^Chan KL, et al. The effect of Eurycoma longifolia on sperm quality of male rats. Nat Prod Commun. (2009)
- ^Akbarsha MA, et al. Antifertility effect of Andrographis paniculata (Nees) in male albino rat. Indian J Exp Biol. (1990)
- ^Akbarsha MA, Murugaian P. Aspects of the male reproductive toxicity/male antifertility property of andrographolide in albino rats: effect on the testis and the cauda epididymidal spermatozoa. Phytother Res. (2000)
- ^ ab c d e f g h i j k l m Rajagopal S, et al. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J Exp Ther Oncol. (2003)
- ^Zhou J, et al. Andrographolide sensitizes cancer cells to TRAIL-induced apoptosis via p53-mediated death receptor 4 up-regulation. Mol Cancer Ther. (2008)
- ^Burns TF, El-Deiry WS. Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. J Biol Chem. (2001)
- ^Wang S. The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway. Oncogene. (2008)
- ^Han Y, et al. Modulation of multidrug resistance by andrographolid in a HCT-8/5-FU multidrug-resistant colorectal cancer cell line. Chin J Dig Dis. (2005)
- ^Yang L, et al. Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells. Cancer Lett. (2009)
- ^ ab c Shi MD, et al. Inhibition of cell-cycle progression in human colorectal carcinoma Lovo cells by andrographolide. Chem Biol Interact. (2008)
- ^ ab c Geethangili M, et al. Cytotoxic constituents from Andrographis paniculata induce cell cycle arrest in jurkat cells. Phytother Res. (2008)
- ^ ab Cytotoxic diterpenoid constituents from Andrographis paniculata Nees, leaves.
- ^Nevins JR, et al. Role of the Rb/E2F pathway in cell growth control. J Cell Physiol. (1997)
- ^Chao HP, et al. Andrographolide exhibits anti-invasive activity against colon cancer cells via inhibition of MMP2 activity. Planta Med. (2010)
- ^ ab Lai YH, et al. The HLJ1-targeting drug screening identified Chinese herb andrographolide that can suppress tumour growth and invasion in non-small-cell lung cancer. Carcinogenesis. (2013)
- ^ ab Sukardiman H, et al. Apoptosis inducing effect of andrographolide on TD-47 human breast cancer cell line. Afr J Tradit Complement Altern Med. (2007)
- ^ ab Kumar S, et al. Andrographolide inhibits osteopontin expression and breast tumor growth through down regulation of PI3 kinase/Akt signaling pathway. Curr Mol Med. (2012)
- ^ ab Tan ML, et al. Identification of genes involved in the regulation of 14-deoxy-11,12-didehydroandrographolide-induced toxicity in T-47D mammary cells. Food Chem Toxicol. (2012)
- ^Cytotoxic Activities of Major Diterpenoid Constituents of Andrographis paniculata. in a Panel of Human Tumor Cell Lines.
- ^ ab Cheung HY, et al. Andrographolide isolated from Andrographis paniculata induces cell cycle arrest and mitochondrial-mediated apoptosis in human leukemic HL-60 cells. Planta Med. (2005)
- ^Matsuda T, et al. Cell differentiation-inducing diterpenes from Andrographis paniculata Nees. Chem Pharm Bull (Tokyo). (1994)
- ^ ab Li Y, et al. Inactivation of PI3K/Akt signaling mediates proliferation inhibition and G2/M phase arrest induced by andrographolide in human glioblastoma cells. Life Sci. (2012)
- ^Singh RP, Banerjee S, Rao AR. Modulatory influence of Andrographis paniculata on mouse hepatic and extrahepatic carcinogen metabolizing enzymes and antioxidant status. Phytother Res. (2001)